159 related articles for article (PubMed ID: 23129452)
21. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
[TBL] [Abstract][Full Text] [Related]
24. Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers.
Suleyman H; Albayrak A; Bilici M; Cadirci E; Halici Z
Inflammation; 2010 Aug; 33(4):224-34. PubMed ID: 20084447
[TBL] [Abstract][Full Text] [Related]
25. The unique pharmacologic profile of nabumetone.
Blower PR
J Rheumatol Suppl; 1992 Nov; 36():13-9. PubMed ID: 1474529
[TBL] [Abstract][Full Text] [Related]
26. Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo.
Kerola M; Vuolteenaho K; Kosonen O; Kankaanranta H; Sarna S; Moilanen E
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):17-21. PubMed ID: 19152549
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers.
van Kraaij DJ; Hovestad-Witterland AH; de Metz M; Vollaard EJ
Br J Clin Pharmacol; 2002 Jun; 53(6):644-7. PubMed ID: 12047490
[TBL] [Abstract][Full Text] [Related]
28. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of nabumetone, naproxen, piroxicam, and diclofenac on rat gastric irritancy following acute exposure to OTC non-steroidal anti-inflammatory agents and other gastric irritants.
Carryl OR; Spangler RS
Scand J Rheumatol; 1995; 24(6):336-41. PubMed ID: 8610216
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
31. In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats.
Laudanno OM; Cesolari JA; Esnarriaga J; San Miguel P; Bedini OA
Dig Dis Sci; 2000 Jul; 45(7):1359-65. PubMed ID: 10961715
[TBL] [Abstract][Full Text] [Related]
32. Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events.
Freston JW
Am J Med; 1999 Dec; 107(6A):78S-88S; discussion 89S. PubMed ID: 10628597
[TBL] [Abstract][Full Text] [Related]
33. Role of prostaglandins and nitric oxide in gastric damage induced by metamizol in rats.
Sánchez S; Martín MJ; Ortiz P; Motilva V; Herrerías JM; Alarcón de la Lastra C
Inflamm Res; 2002 Aug; 51(8):385-92. PubMed ID: 12234055
[TBL] [Abstract][Full Text] [Related]
34. Role of mucus reduction and luminal acid elevation in increased susceptibility of stomach to nonsteroidal antiinflammatory drug-induced injury in arthritic rats.
Okuyama K; Jinbo M; Saito N; Igarashi S; Narita H; Kinoshita M
Dig Dis Sci; 2000 Nov; 45(11):2175-81. PubMed ID: 11215734
[TBL] [Abstract][Full Text] [Related]
35. Effect of nabumetone treatment on vascular responses of the thoracic aorta in rat experimental arthritis.
Ulker S; Onal A; Hatip FB; Sürücü A; Alkanat M; Koşay S; Evinç A
Pharmacology; 2000 Apr; 60(3):136-42. PubMed ID: 10754450
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers.
Agrawal NM; Caldwell J; Kivitz AJ; Weaver AL; Bocanegra TS; Ball J; Dhadda S; Hurley S; Hancock L
Clin Ther; 1999 Apr; 21(4):659-74. PubMed ID: 10363732
[TBL] [Abstract][Full Text] [Related]
37. Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions.
Ishiwata Y; Okamoto M; Yokochi S; Hashimoto H; Nakamura T; Miyachi A; Naito Y; Yoshikawa T
J Pharm Pharmacol; 2003 Feb; 55(2):229-37. PubMed ID: 12635655
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
[TBL] [Abstract][Full Text] [Related]
39. Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone.
Hilleman DE; Mohiuddin SM; Lucas BD
Am J Med; 1993 Aug; 95(2A):30S-34S. PubMed ID: 8357000
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cyclooxygenase activity by metamizol.
Campos C; de Gregorio R; García-Nieto R; Gago F; Ortiz P; Alemany S
Eur J Pharmacol; 1999 Aug; 378(3):339-47. PubMed ID: 10493111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
